ArticlePDF Available

Clinical Usefulness of Transcranial Doppler as a Screening Tool for Early Cerebral Hypoxic Episodes in Patients with Moderate and Severe Traumatic Brain Injury

Authors:

Abstract and Figures

Background Brain tissue oxygenation (PbtO2) in traumatic brain injury (TBI) is known to be dependent on cerebral blood flow (CBF) which remains difficult to assess during the very early phase of TBI management. This study evaluates if blood flow velocity measurement with 2D color-coded transcranial Doppler (TCD) can predict cerebral hypoxic episodes in moderate-to-severe TBI measured with a PbtO2 probe. Methods This is a prospective observational study of serial TCD measurements to assess blood flow velocity and its association with PbtO2. Measurements were done bilaterally on the middle cerebral artery (MCA) early after the insertion of PbtO2 monitoring, daily for 5 days and during dynamic challenge tests. Physiological parameters affecting PbtO2 and Doppler velocities were collected simultaneously (PaO2, PaCO2, hemoglobin [Hb] level, intracranial pressure, and cerebral perfusion pressure [CPP]). Results We enrolled 17 consecutive patients with a total of 85 TCD studies. Using 2D color-coded TCD, signal acquisition was successful in 96% of the cases. Twenty-nine (34%) TCD measures were performed during an episode of cerebral hypoxia (PbtO2 ≤ 20 mmHg). For early episodes of cerebral hypoxia (occurring ≤ 24 h from trauma), all Vmean < 40 cm/s were associated with an ipsilateral PbtO2 ≤ 20 mmHg (positive predictive value 100%). However, when considering all readings over the course of the study, however, we found no correlation between PbtO2 and MCA’s mean blood flow velocity (Vmean). Vmean is also positively correlated with PaCO2, whereas PbtO2 is also correlated with PaO2, CPP, and Hb level. Conclusions Early TCD measurements compatible with low CBF (mean velocity < 40 cm/s) detect brain tissue hypoxia early after TBI (≤ 24 h) and could potentially be used as a screening tool before invasive monitoring insertion to help minimize time-sensitive secondary injury. Various factors influence the relationship between Vmean and PbtO2, affecting interpretation of their interaction after 24 h.
Content may be subject to copyright.
Neurocrit Care
https://doi.org/10.1007/s12028-019-00763-y
ORIGINAL WORK
Clinical Usefulness ofTranscranial Doppler
asa Screening Tool forEarly Cerebral Hypoxic
Episodes inPatients withModerate andSevere
Traumatic Brain Injury
C. Sokoloff1, D. Williamson2,3, K. Serri1,2,4, M. Albert1,2,4, C. Odier5,6, E. Charbonney1,2,4 and F. Bernard1,2,4* on
behalf of for the ÉRESI Reseach Group (Équipe de Recherche En Soins Intensifs)
© 2019 Springer Science+Business Media, LLC, part of Springer Nature and Neurocritical Care Society
Abstract
Background: Brain tissue oxygenation (PbtO2) in traumatic brain injury (TBI) is known to be dependent on cerebral
blood flow (CBF) which remains difficult to assess during the very early phase of TBI management. This study evalu-
ates if blood flow velocity measurement with 2D color-coded transcranial Doppler (TCD) can predict cerebral hypoxic
episodes in moderate-to-severe TBI measured with a PbtO2 probe.
Methods: This is a prospective observational study of serial TCD measurements to assess blood flow velocity and
its association with PbtO2. Measurements were done bilaterally on the middle cerebral artery (MCA) early after the
insertion of PbtO2 monitoring, daily for 5 days and during dynamic challenge tests. Physiological parameters affecting
PbtO2 and Doppler velocities were collected simultaneously (PaO2, PaCO2, hemoglobin [Hb] level, intracranial pres-
sure, and cerebral perfusion pressure [CPP]).
Results: We enrolled 17 consecutive patients with a total of 85 TCD studies. Using 2D color-coded TCD, signal
acquisition was successful in 96% of the cases. Twenty-nine (34%) TCD measures were performed during an epi-
sode of cerebral hypoxia (PbtO2 20 mmHg). For early episodes of cerebral hypoxia (occurring 24 h from trauma),
all Vmean < 40 cm/s were associated with an ipsilateral PbtO2 20 mmHg (positive predictive value 100%). How-
ever, when considering all readings over the course of the study, however, we found no correlation between PbtO2
and MCA’s mean blood flow velocity (Vmean). Vmean is also positively correlated with PaCO2, whereas PbtO2 is also
correlated with PaO2, CPP, and Hb level.
Conclusions: Early TCD measurements compatible with low CBF (mean velocity < 40 cm/s) detect brain tissue
hypoxia early after TBI ( 24 h) and could potentially be used as a screening tool before invasive monitoring inser-
tion to help minimize time-sensitive secondary injury. Various factors influence the relationship between Vmean and
PbtO2, affecting interpretation of their interaction after 24 h.
Keywords: Traumatic brain injury, Transcranial Doppler, Brain oxygenation
*Correspondence: bernard.francis@gmail.com
1 Department of Medicine, Hôpital du Sacré-Coeur de Montréal, Centre
intégré universitaire de santé et de services sociaux (CIUSSS) du Nord-de-
l’Ile-de-Montréal, 5400 Boul Gouin O, Montréal, Québec H4J 1C5, Canada
Full list of author information is available at the end of the article
Introduction
Substantial improvement in severe traumatic brain injury
(TBI) outcomes has been achieved in the last 40years
due to a better understanding of the pathophysiology of
head injury and the introduction of multimodal moni-
toring (MMM) [13]. Among modalities, brain tissue
oxygen (PbtO2) monitoring is increasingly used to guide
optimal brain perfusion and oxygenation [46]. In fact,
PbtO2 has been independently associated with short-
term outcomes and represents a better indicator of poor
outcome than intracranial pressure (ICP) or cerebral
perfusion pressure (CPP) [4]. However, MMM is often
invasive and requires neurosurgical expertise for inser-
tion, which involves potential delays before information
is available for clinical use.
Studies have shown that 60–80% of TBI patients go
through an initial phase ofcerebral hypoperfusion dur-
ing the early post-traumatic period, termed «early low-
flow» [58]. e pathophysiology of this phenomenon
is not fully understood, but ICP and CPP may be within
normal limits. Microcirculatory vasoconstriction and
misdistribution of regional cerebral blood flow (CBF)
may be responsible for this low-flow state [7, 9]. us,
clinicians could be falsely reassured by arterial pres-
sure measurements. Monitoring PbtO2 avoids indirect
assumptions of O2 delivery, while ICP and CPP remain in
the normal range [4] but isnot available in the emergency
department.
Transcranial Doppler (TCD) can be used in the emer-
gency department and has been shown to detect elevated
ICP and low CPP [10, 11]. In particular, the mean blood
flow velocity (Vmean) of the middle cerebral artery
(MCA) has been shown to detect changes in ICP [12],
PbtO2 [9, 12] and early low-flow states [7]. To our knowl-
edge, only two studies have adequately investigated the
relation between Vmean and PbtO2 [9, 12]. One focused
on the early post-traumatic period and showed a strong
correlation between PbtO2 and Vmean within 8h of the
trauma [9]. However, this observation was a secondary
outcome of the study. Furthermore, other determinants
of PbtO2 or factors influencing TCD measurements were
not taken into account such as PaCO2 or PaO2. e sec-
ond studied the reactivity of cerebral oxygen monitors
and Doppler indices in response to fluctuations of arte-
rial blood pressure without correlating them directly or
identifying absolute Doppler values associated with cer-
ebral hypoxia [12]. Finally, TCD used in these studies did
not rely on 2D color-coded Doppler to identify MCAs.
In an attempt to assess the usefulness of TCD as a
screening tool for early hypoxic episodes, we evaluated
the association between mean velocities measured by
2D color-coded TCD in the MCA and PbtO2 in patients
with moderate-to-severe TBI. We hypothesized that
time-averaged Vmean measured in the MCA would
detect early brain hypoxic episodes after TBI, particularly
in the first 24h after TBI. Our main objective was to eval-
uate the association of Vmean with PbtO2. e secondary
objective was to evaluate factors influencing Vmean and
PbtO2 measurement.
Methods
Subjects
is prospective observational study was conducted at
the Neuro-Critical Care Unit of Hôpital du Sacré-Coeur
de Montréal, an adult academic Level 1 trauma cen-
tre. We consecutively recruited every patient with non-
penetrating TBI who required the insertion of a PbtO2
monitor between May 2015 and December 2015. PbtO2
and ICP monitors were inserted simultaneously. Patients
were excluded if they had a penetrating brain injury or
a diagnosis of brain death on arrival. e research ethics
committee approved the study protocol, and written con-
sent was obtained from the patient’s next of kin (REB#
2015-1134).
Standard Monitoring andCare
As part of standard of care, invasive mean arterial pres-
sure (MAP) leveled at the foramen of Monroe, ICP, CPP,
and PbtO2 weremonitored continuously. ICP was moni-
tored with an intraparenchymal probe (Camino®, San
Diego, USA) or with an external ventricular drain. PbtO2
was monitored with a Clark-type electrode (Licox®,
Integra Lifesciences, USA) inserted according to manu-
facturer’s recommendation. All probes were adequately
positioned in normal appearing white matter as con-
firmed with a brain computed tomography (CT) scan
or FiO2 challenge. Two hours were added for calibration
before the readings were considered reliable (equilibra-
tion time). When possible, a pulse contour analysis sys-
tem (Flotrac®, Vigileo®, Edward Lifesciences, USA) was
added to the arterial line to monitor the cardiac output
and stroke volume. In accordance with our local protocol
[13] and 2007 Brain Trauma Foundation guidelines [14],
systematic therapeutic measures were undertaken every
time ICP was 20 mmHg, PbtO2 was 20 mmHg , or
CPP was < 60mmHg. Patients with mass lesions under-
went surgical intervention for decompression or hema-
toma removal as judged necessary by the neurosurgical
team.
2D Color‑Coded Transcranial Doppler Measurements
Every patient had serial 2D color-coded TCD ultra-
sonography performed by one investigator (C. Sokoloff)
to assess blood flow velocity of the MCA through the
temporal window as described by Aaslid et al. [15]
while the patient was in the ED or intensive care. Color
duplex images were first recorded using an echo-Doppler
1–5MHz transducer. After identifying the M1 segment
of the MCA at a depth of 4.5–6cm and making an angle
adjustment, the artery was interrogated with pulse-wave
Doppler. For every MCA insonation, we recorded maxi-
mal (Vmax), minimal (Vmin), and Vmean, as well as
the pulsatility index (PI) calculated as (Vmax Vmin)/
Vmean ipsilateral to PbtO2. At least three measurements
on the same vessel segment were taken, and the signal
with the highest value was recorded. Measurements were
taken bilaterally as soon as possible after the insertion
of PbtO2, daily for a total of 5days, and during dynamic
challenge tests. Dynamic challenge tests evaluated cer-
ebral vascular autoregulation, PbtO2 reactivity to 100%
oxygen, and cerebrovascular reactivity to CO2 (see sup-
plements for details). We defined a low-flow velocity state
as a Vmean < 40cm/s and a high flow state as > 100cm/s
as previously reported in the literature, the normal range
being 43–67cm/s [9]. When the Vmean was 120cm/s ,
the internal carotid artery was insonated to calculate
a Lindegaard ratio (ratio of MCAVmean/ICAVmean), to dif-
ferentiate vasospasm from hyperemia. Vasospasm was
defined by a Vmean 120cm/s associated with a Linde-
gaard ratio > 3, whereas hyperemia was defined as
Vmean 120cm/s associated with a Lindegaard ratio 3.
We collected the following data: demographic informa-
tion (age and sex) and trauma characteristics (date and
time of trauma, initial Glasgow Coma Scale [GCS], Injury
Severity Score, Marshall and Rotterdam scores on the
initial cerebral scan, and need for surgical intervention
and craniectomy). Location of the PbtO2 monitor (left
or right) was recorded. Simultaneously to every TCD,
we recorded variables that could affect TCD velocities or
PbtO2 values including: time since injury, pulse rate, sys-
tolic, diastolic, and MAP, oxygen saturation (SaO2), tem-
perature, blood gas result (PaO2 and PaCO2), hemoglobin
level (Hb), inspired oxygen fraction delivered (FiO2), car-
diac index (CI), and vasoactive medications. An Extended
Glasgow Outcome Scale (GOS-E) was assessed 6months
after injury. e cause of death and the reason for with-
drawal of life-sustaining therapy, if applicable, were also
collected.
Statistical Analysis
e sample size was calculated to verify the association
between PbtO2 and Vmean, derived from the data from
Van Santbrink which showed a correlation of r = 0.73 [9].
Eleven patients were required to establish a simple corre-
lation considering a set error of 0.05 and a desired power
of 80% (G*Power 3.1) [16]. In order to detect a correla-
tion of r = 0.70, we recruited 17 patients.
TCD values used for analysis were always the ones
acquired on the same side as the PbtO2 measurements.
Descriptive values are reported as means with stand-
ard deviations or medians with inter-quartiles range,
as appropriate. Normal distribution of variables was
assessed through visual inspection, Kolmogorov, and
Shapiro tests. Correlations were established using a sim-
ple Pearson coefficient for normally distributed variables
and with Spearman correlation for nonparametric values
(SPSS v.24).
Results
We included 17 patients (14 males and three females), of
which 16 had a severe TBI and one had a moderate TBI
(initial GCS of 10). Eleven patients (65%) had diffuse cer-
ebral injury and six lateralized injury. Fifteen patients
(88%) had a subarachnoid hemorrhage reported on the
admission CT scan. Eight patients (47%) underwent a
surgical intervention, of which seven were initial, primary
decompressive hemicraniectomies and one a secondary
intervention for persistently elevated ICP and low PbtO2
after an attempt at medical management. e 30-day and
6-month mortality rates in our population were 53% and
65%, respectively. Patient characteristics can be found in
Table1.
All patients had continuous ICP and PbtO2 monitor-
ing inserted within a median of 7h (IQR 5–14.5h) from
the trauma. e majority of PbtO2 probes (n = 15, 82%)
were inserted on the right side according to local prac-
tice, except for three patients who had PbtO2 device
Table 1 Patient characteristics
GCS Glasgow Coma Scale, IQR interquartile range, SAH subarachnoid
hemorrhage, SD standard deviation
Variables N = 17
Mean age, years (SD) 44 (± 15)
Gender, female/male 3/14
Mean admission GCS (SD) 5 (± 2)
Trauma characteristics
Concomitant extracranial trauma (%) 10 (59)
Diffuse cerebral injury (%) 11 (65)
Traumatic SAH (%) 15 (88)
Median Rotterdam Score (IQR) 4 (2–4)
Median Marshall Score (IQR) 5(2–5)
Injury Severity Score (IQR) 27 (19)
Surgical characteristics
Surgical intervention (%) 8 (47)
Decompressive hemicraniectomy (%) 7 (41)
Extended Glasgow Outcome Scale at 6 months
1 (death) 11
2–4 (vegetative state or severe disability) 2
5–6 (moderate disability) 3
7–8 (good recovery) 1
positioned under direct vision during craniectomy
(tunneled catheter). Of the six patients with unilateral
injury, four had surgery and the PbtO2 probe inserted
on the side of injury; the other two did not have sur-
gery with the probe inserted on the contralateral side.
Twelve patients (71%) had cardiac output monitored.
A total of 85 TCD examinations were performed
(mean of five TCD/patient). Doppler signal with 2D
color-coded Doppler was obtained in 96% of patients.
e first TCD values were obtained at a median of
19.5h (IQR 13.2–26.3h) after TBI and were obtained
within 8h in two (12%) and < 24h in ten patients (59%).
When considering all TCD readings, we found no cor-
relation between PbtO2 and ipsilateral Vmean (Fig.1).
However, a correlation was shown in readings collected
within 24 h of trauma (r2 = 0.41; p = 0.035, Fig. 2).
All TCD Vmean below 40cm/s in the first 24h after
TBI (n = 6) were associated with PbtO2 values below
20mmHg (positive predictive value 100%).
Twenty-four (28%) TCD measures were done during
an episode of cerebral hypoxia (PbtO2 < 20 mmHg) and
Vmean varied from 15 to 164cm/s, mean 71 ± 38cm/s
(Figs. 1, 2). Sensitivity and specificity of Vmean
of < 40cm/s to detect PbtO2 below 20mmHg were 38%
and 58%, respectively. According to predefined criteria,
we observed vasospasm in only one patient. Excluding
the Vmean obtained from this patient, episodes of low
PbtO2 corresponded to a mean Vmean of 48 ± 27 cm/s.
No correlation was seen between Vmean values and Hb,
temperature, PaO2, ICP, MAP, CPP, or CI (all p > 0.05).
A correlation was seen between Vmean and PCO2 (R2
0.351, p = 0.003).
A correlation was also found between PbtO2 and PaO2
(R2 0.429, p < 0.001), CPP (R2 0.450, p < 0.001), and Hb
(R2 0.272, p = 0.027) but not temperature, PI, PCO2, ICP,
or CI (all p > 0.05). Nine patients had dynamic challenge
tests performed (total of 20 challenges). All had pre-
served autoregulation, reactivity to O2 and CO2. ere
was no correlation between Vmean and PbtO2 during
dynamic challenge tests (all p > 0.05).
Discussion
Our findings suggest that measurements compatible with
low CBF velocity (Vmean < 40cm/s) collected in the first
24h after TBI are associated with brain tissue hypoxia
(PbtO2 < 20 mmHg). However, there is no correlation
between PbtO2 and Vmean when all measurements are
considered. We were able to obtain a good TCD signal
with 2D color-guided ultrasound in 96% of insonation
attempts.
is association is clinically important for two reasons.
First, considering it takes a mean of 7h for the PbtO2
monitoring system to be inserted, it was important to
confirm that TCD measures can be used as a surrogate
marker of cerebral ischemia. Our results confirm the
association between the early low velocities and paren-
chymal hypoxia, which in turn is known to be associated
with a poor outcome [17]. Second, our results suggest the
24h time frame following TBI in which the ultrasound
might be of interest in detecting cerebral hypoxia. Simi-
larly, van Santbrink etal. [9] evaluated the evolution of
TCD measurements in the early post-traumatic period.
ey found a stronger correlation between Vmean and
PbtO2 (r = 0.73). is correlation was limited to the first
8h after TBI and could not be replicated beyond that
time frame. Our study confirms these previous findings
and suggests that despite improvement in the manage-
ment in TBI patients in neuro-critical care, there is a
need to focus on improving very early management.
Our results indicate that episodes of early low-flow
detected by TCD are associated with brain hypoxia as
measured by PbtO2 [7]. It must be appreciated that more
Fig. 1 Relationship between PbtO2 and Vmean for all readings
Fig. 2 Relationship between PbtO2 and ipsilateral Vmean for meas-
ures at 24 h of trauma. Gray zone showing results associated with a
Vmean 40 cm/s and PbtO2 20 mmHg
than a third of patients with severe TBI may have early
brain ischemia detected by SjvO2 on the initial invasive
cerebral monitoring after resuscitation despite MAP of
80mmHg or higher [18]. Since TCD is noninvasive and
readily available at the bedside, it might identify patients
with cerebral hypoxia before invasive monitoring is avail-
able to prevent secondary injuries. is strategy has been
investigated in two small pilot observational studies
[19, 20]. In both studies, a specific therapy (increase in
MAP and administration of osmotic agents) was adjusted
depending on TCD results collected during the initial
emergency evaluation and before any invasive intrac-
ranial monitoring was inserted. Following the observa-
tion that initially abnormal TCD results improved after
treatment, the authors concluded that TCD was useful
in detecting patients with an impaired cerebral perfu-
sion. However, both studies were performed in centers
where early use of TCD was a standard of care and their
results were not correlated with direct CBF or PbtO2
measurements.
e usefulness of TCD to predict cerebral hypoxia
seems to diminish as time after trauma increases and
despite a statistically significant correlation between
PbtO2 and Vmean, this association does not seem to be
clinically relevant. is is probably explained by the com-
plex interaction of pathophysiological conditions at play
in an injured brain during the first few days after TBI.
Various determinants of Vmean and PbtO2 can alter
the relationship between these two variables [13]. For
example, increasing PaO2 can correct cerebral hypoxia
measured by PbtO2 even in the presence of decreased
CBF [16, 21]. Also, diffusion being the rate limiting step
of oxygen delivery to the brain, cerebral hypoxia can be
observed despite adequate CBF and Vmean as diffusion
conditions can deteriorate over a few days after TBI [22].
Microvascular collapse, endothelial swelling, and perivas-
cular edema play a role in the increased diffusion gradi-
ent following head injury [22, 23]. Not surprisingly and
in line with these pathophysiological considerations, we
observed a strong correlation between PaO2 and PbtO2
in our study. Finally, various situations can occur where
Vmean can be increased, while CBF is actually reduced,
the best example of this being cerebral vasospasm.
Hyperventilation can potentially have the same effect on
cerebral hemodynamics and occurs frequently after TBI
[21]. Accordingly, PaCO2 was positively correlated with
Vmean in our study. It must be emphasized that normal
TCD values do not mean that there is no brain hypoxia.
It is worth mentioning that using 2D color-coded TCD,
we were able to obtain reliable measurements 96% of the
time. is is in line with a recent trial using the same
technique in mild-to-moderate TBI reporting a 99%
acquisition rate [24]. e fact that anatomical structures
(clinoid process, temporal lobe, brain stem, etc.) can ini-
tially be identified coupled with colored visualization of
the circle of Willis probably explains this very low rate
of “no acoustic window available.” at being said, TCD
interpretation requires skill and expertise. An abnormal
TCD detected in the emergency department would war-
rant confirmation by an experienced sonographer.
Limitations
Our study has several limitations and important fac-
tors to consider when interpreting the results. First, this
is a small single-center study in which we considered
all measures obtained in our patients for our statistical
analyses. As some of these data are non-independent,
this may have influenced our correlation results. It should
also be noted that our population represents very severe
TBI since mortality rate was 53% and five patients had
moderate disability (GOS-E 5–6). Most patients died
following withdrawal of care (6/11) and because of cat-
astrophic neurologic injury leading to organ donation
(2/11). e reason for this high mortality rate is prob-
ably circumstantial and associated with family wishes in
a shared decision making process. A 50% mortality rate
has been reported after severe TBI [25]. Also, we were
unable to get the first measurements within 8h of the
trauma because of delays in PbtO2 probe insertion due to
patient transfer from a referral center or urgent surgery.
However, it is conceivable that low Vmean (< 40 cm/s)
at earlier time point would also be associated with cer-
ebral hypoxia. e fact that the ultrasonographer was not
blinded from the PbtO2 value could have introduced a
reporting bias although a rigorous methodology was used
to perform the examination. Finally, despite treatment
management being protocolized, we cannot exclude that
confounding variables affected TCD and PbtO2 meas-
urements. is seems unlikely since we collected mul-
tiple determinants of these two measures at the same
time. at being said, it should be noted that we did not
have the power to conduct multivariate analysis to fully
explore this matter.
Conclusion
TCD measurements compatible with low CBF veloc-
ity (Vmean < 40cm/s) collected in the first 24h seem to
correlate with brain tissue hypoxia. Interpreting Doppler
and PbtO2 values, one should take into consideration that
Vmean seems to be influenced by PaCO2 and that PbtO2
is influenced by PaO2, CPP, and Hb in this study. Further
studies are needed to verify if this modality can be used
as a screening tool to help minimize time-sensitive sec-
ondary injuries.
Electronic supplementary material
The online version of this article (https ://doi.org/10.1007/s1202 8-019-00763 -y)
contains supplementary material, which is available to authorized users.
Author details
1 Department of Medicine, Hôpital du Sacré-Coeur de Montréal, Centre
intégré universitaire de santé et de services sociaux (CIUSSS) du Nord-de-
l’Ile-de-Montréal, 5400 Boul Gouin O, Montréal, Québec H4J 1C5, Canada.
2 Research Center, Hôpital du Sacré-Coeur de Montréal, Centre intégré
universitaire de santé et de services sociaux (CIUSSS) du Nord-de-l’Ile-de-
Montréal, Montréal, Canada. 3 Pharmacy Faculty, Université de Montréal,
Montréal, Canada. 4 Faculty of Medicine, Université de Montréal, Montréal,
Canada. 5 Department of Medicine, Centre Hospitalier de l’Université de Mon-
tréal, Montréal, Canada. 6 Faculty of Neurosciences, Université de Montréal,
Montréal, Canada.
Author Contributions
CS, DW, and FB design the study. KS, MA, CO, and EC provided significant
feedback on study design. CS collected the data, and FB vouches for the
accurateness of it. All authors participated in interpreting the data. CS and FB
drafted the article. DW, KS, MA, CO, and EC read the papers and provided criti-
cal feedback and suggestions to improve the manuscript. The final manuscript
was approved by all authors.
Source of Support
There was no financial support for this work.
Conflicts of Interest
All authors have nothing to disclose.
Ethical Approval
This work was approved by our local ethics committee.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in pub-
lished maps and institutional affiliations.
References
1. Lu J, Marmarou A, Choi S, Maas A, Murray G, Steyerberg EW, et al. Mortal-
ity from traumatic brain injury. Acta Neurochir Suppl. 2005;95:281–5.
2. Bouzat P, Marques-Vidal P, Zerlauth J-B, Sala N, Suys T, Schoettker P, et al.
Accuracy of brain multimodal monitoring to detect cerebral hypoperfu-
sion after traumatic brain injury*. Crit Care Med. 2015;43:445–52.
3. Gerber LM, Chiu Y-L, Carney N, Härtl R, Ghajar J. Marked reduction in
mortality in patients with severe traumatic brain injury. J Neurosurg.
2013;119:1583–90.
4. Oddo M, Levine JM, Mackenzie L, Frangos S, Feihl F, Kasner SE, et al. Brain
hypoxia is associated with short-term outcome after severe traumatic
brain injury independent of intracranial hypertension and low cerebral
perfusion pressure. Neurosurgery. 2011;69:1037–45.
5. Obrist WD, Langfitt TW, Jaggi JL, Cruz J, Gennarelli TA. Cerebral blood flow
and metabolism in comatose patients with acute head injury. Relation-
ship to intracranial hypertension. J Neurosurg. 1984;61:241–53.
6. Bouma GJ, Muizelaar JP, Choi SC, Newlon PG, Young HF. Cerebral circula-
tion and metabolism after severe traumatic brain injury: the elusive role
of ischemia. J Neurosurg. 1991;75:685–93.
7. Martin NA, Patwardhan RV, Alexander MJ, Africk CZ, Lee JH, Shalmon E,
et al. Characterization of cerebral hemodynamic phases following severe
head trauma: hypoperfusion, hyperemia, and vasospasm. J Neurosurg.
1997;87:9–19.
8. Marion DW, Darby J, Yonas H. Acute regional cerebral blood flow changes
caused by severe head injuries. J Neurosurg. 1991;74:407–14.
9. van Santbrink H, Schouten JW, Steyerberg EW, Avezaat CJJ, Maas AIR.
Serial transcranial Doppler measurements in traumatic brain injury
with special focus on the early posttraumatic period. Acta Neurochir.
2002;144:1141–9.
10. Chan KH, Miller JD, Dearden NM, Andrews PJ, Midgley S. The effect of
changes in cerebral perfusion pressure upon middle cerebral artery
blood flow velocity and jugular bulb venous oxygen saturation after
severe brain injury. J Neurosurg. 1992;77:55–61.
11. Brandi G, Béchir M, Sailer S, Haberthür C, Stocker R, Stover JF. Transcranial
color-coded duplex sonography allows to assess cerebral perfusion
pressure noninvasively following severe traumatic brain injury. Acta
Neurochir. 2010;152:965–72.
12. Budohoski KP, Zweifel C, Kasprowicz M, Sorrentino E, Diedler J, Brady KM,
et al. What comes first? The dynamics of cerebral oxygenation and blood
flow in response to changes in arterial pressure and intracranial pressure
after head injury. Br J Anaesth. 2012;108:89–99.
13. Dellazizzo L, Demers SP, Charbonney E, Williams V, Serri K, Albert M,
Giguère JF, Laroche M, Williamson D, Bernard F. Minimal PaO2 threshold
after traumatic brain injury and clinical utility of a novel brain oxygena-
tion ratio. J Neurosurg. 2018;1:1–9.
14. Brain Trauma Foundation, American Association of Neurological Sur-
geons, Congress of Neurological Surgeons. Guidelines for the manage-
ment of severe traumatic brain injury. J Neurotrauma. 2007. pp. S1–106.
15. Aaslid R, Markwalder TM, Nornes H. Noninvasive transcranial Doppler
ultrasound recording of flow velocity in basal cerebral arteries. J Neuro-
surg. 1982;57:769–74.
16. Faul F, Erdfelder E, Lang A-G, Buchner A. G*Power 3: a flexible statistical
power analysis program for the social, behavioral, and biomedical sci-
ences. Behav Res Methods. 2007;39:175–91 (2nd ed.).
17. Maloney-Wilensky E, Gracias V, Itkin A, Hoffman K, Bloom S, Yang W, et al.
Brain tissue oxygen and outcome after severe traumatic brain injury: a
systematic review. Crit Care Med. 2009;37:2057–63.
18. Vigué B, Ract C, Benayed M, Zlotine N, Leblanc PE, Samii K, et al. Early
SjvO2 monitoring in patients with severe brain trauma. Intensive Care
Med. 1999;25:445–51.
19. Ract C, Le Moigno S, Bruder N, Vigué B. Transcranial Doppler ultrasound
goal-directed therapy for the early management of severe traumatic
brain injury. Intensive Care Med. 2007;33:645–51.
20. Tazarourte K, Atchabahian A, Tourtier JP, David JS, Ract C, Savary D, et al.
Pre-hospital transcranial Doppler in severe traumatic brain injury: a pilot
study. Acta Anaesthesiol Scand. 2011;55:422–8.
21. Neumann JO, Chambers IR, Citerio G, Enblad P, Gregson BA, Howells T,
et al. The use of hyperventilation therapy after traumatic brain injury
in Europe: an analysis of the BrainIT database. Intensive Care Med.
2008;34:1676–82.
22. Menon DK, Coles JP, Gupta AK, Fryer TD, Smielewski P, Chatfield DA, et al.
Diffusion limited oxygen delivery following head injury*. Crit Care Med.
2004;32:1384–90.
23. Veenith TV, Carter EL, Geeraerts T, Grossac J, Newcombe VFJ, Outtrim J,
et al. Pathophysiologic mechanisms of cerebral ischemia and diffusion
hypoxia in traumatic brain injury. JAMA Neurol. 2016;73:542–50.
24. Bouzat P, Almeras L, Manhes P, Sanders L, Levrat A, David J-S, et al. Tran-
scranial Doppler to predict neurologic outcome after mild to moderate
traumatic brain injury. Anesthesiology. 2016;125:346–54.
25. Turgeon AF, Lauzier F, Simard J-F, Scales DC, Burns KEA, Moore L, et al.
Mortality associated with withdrawal of life-sustaining therapy for
patients with severe traumatic brain injury: a Canadian multicentre
cohort study. CMAJ. 2011;183:1581–8.
... [59][60][61][62][63][64] Therefore, TCD is an extremely useful modality in monitoring the temporal course of PTV and ICH after TBI in adult and pediatric population. [64][65][66][67][68][69][70][71] Even though repeat angiography is unavoidable in most TBI with tSAH patients, TCD can guide the timing of this procedure and the tailoring of aggressive treatment regimens. 59,60,64 The key is not only to predict compromised perfusion by TCD, but to identify patients going into PTV and to quickly confirm PTV when subtle signs are present, before apparent neurologic deterioration. ...
... Although the second peak usually is not associated with a worsening of symptoms, these patients were more likely to exhibit clinical symptoms during the first CBFV peak. 72 The high sensitivity of TCD to identify abnormally high CBFVs due to the onset of PTV demon-strates that TCD is an excellent first-line examination to identify those patients who may need urgent aggressive treatment and it could be used in ED. [67][68][69] In addition, a dedicated and experienced team of neurologists, neurosurgeons, neurointensivists and neuroradiologists are required to provide the best available care and better outcome for those patients suffering TBI and interested in reducing the adverse outcomes associated with tSAH. Future studies are clearly needed to determine the extent to which PTV causes cerebral ischemia and infarction, and whether its development is directly affected by tSAH. ...
... Numerous studies have shown the effectiveness of TCD in diagnosing cerebral PTV both in anterior and posterior circulation following aSAH (Quality of evidence: class II; Strength of recommendation: type B). 69,[83][84][85] Data on sensitivity, specificity, and predictive value of TCD for PTV after tSAH are needed. Data are insufficient regarding how use of TCD affects clinical outcomes after tSAH (Type U). ...
Article
Full-text available
Neurologists, neurosurgeons, and neurointensivists, including military, have a large armamentarium of diagnostic and monitoring devices available to detect primary and secondary brain injury and guide therapy in patients with acute traumatic brain injury (TBI) to avoid cerebral ischemia due to the posttraumatic vasospasm (PTV) and intracranial hypertension (ICH). This review summarizes the advantages and the specific roles of transcranial Doppler (TCD) ultrasonography for patients with acute and longterm effects of TBI. In critical care setting numerous publications showed that TCD is predictive of angiographic PTV and onset of ICH. The post TBI status of cerebrovascular reactivity and cerebral hemodynamics also has important implications with regard to the treatment of long-term effects of mild TBI (mTBI). Today it is abundant evidence that TCD is an important tool for monitoring the natural course of acute moderate and severe TBI, for evaluating the effect of medical treatment or intervention, for forecasting, and for identifying high-risk patients for onset of cerebral ischemia after TBI. TCD makes good clinical and economic sense as it is a reliable, quantitative, non-invasive and non-expensive “biomarker” to the acute clinical manifestations of TBI. TCD clinical utilization holds promise for better detection, characterization, and monitoring of objective cerebral hemodynamics changes in symptomatic patients with TBI not readily apparent by standard CT or conventional MRI techniques. TCD utilization will improve the sensitivity of neuroimaging to subtle brain perturbations and combining these objective measures with careful clinical characterization of patients may facilitate better understanding of the neural bases and treatment of the signs and symptoms of TBI. This review summarizes the advantages and the specific roles of TCD ultrasonography for patients with acute and long-term effects of TBI.
... El aumento de la demanda de oxígeno de las células inmunes infiltradas, el suministro reducido de sustratos metabólicos por los coágulos sanguíneos y la compresión de los vasos sanguíneos, y la atelectasia del pulmón contribuyen a la hipoxia tisular durante la inflamación, induciendo hipoxemia y desencadenando más citocinas proinflamatorias. 31, [51][52][53][54][55] La hipoxia tisular puede afectar significativamente el desarrollo o la atenuación de la inflamación al causar la regulación de la expresión génica dependiente de hipoxia, induciendo varios factores de transcripción, que desempeñan un papel central en la estimulación de las citocinas proinflamatorias. En realidad, existe una estrecha interrelación entre la hipoxemia generada por la falla respiratoria, la tormenta de citocinas, la falla multiorgánica, el SDRA, y la mortalidad de los pacientes. ...
... 47 These associations of smell and taste dysfunctions and CoV-2 are reliable with case reports relating a patient with SARS with long term anosmia after recovery from respiratory distress, with the observation that olfactory function is usually altered after infection with endemic coronaviruses, and with data indicating that deliberate experimental infection of humans with CoV-2 raises the thresholds at which smells can be sensed. [48][49][50][51][52] A highly published news on this issue came when National Basketball Association player Rudy Gobert trapped the coronavirus, and complained loss of smell and taste. 51 Post-viral anosmia and is one of the leading causes of loss of sense of smell in adults, accounting for up to 40% cases of anostmia. ...
... [48][49][50][51][52] A highly published news on this issue came when National Basketball Association player Rudy Gobert trapped the coronavirus, and complained loss of smell and taste. 51 Post-viral anosmia and is one of the leading causes of loss of sense of smell in adults, accounting for up to 40% cases of anostmia. Viruses responsible of the common cold are well known to cause post-infectious loss of smell, and over 200 different viruses are known to cause upper respiratory tract infections. ...
Thesis
Full-text available
Antecedentes: En diciembre de 2019, en la ciudad de Wuhan, China comenzó la terrible pandemia de Covid-19, que hasta el día hoy ha afectado a 55,207,050 pacientes, con un total de 1,330,203 fallecidos, números que crecen cada día. Esta pandemia es sólo comparada con la llamada “Fiebre Española”, ocurrida en 1918. El virus causante de esta enfermedad es el SARS-CoV-2, que provoca un síndrome respiratorio agudo especialmente severo. No obstante, recientemente se ha documentado además de los síntomas sistémicos y respiratorios, un porciento elevado de los pacientes desarrolla síntomas neurológicos, que en muchos casos son la causa fundamental de la muerte de los enfermos, como es el “síndrome de distrés respiratorio agudo”. Objetivo: Evaluar las complicaciones ocurridas en el sistema nervioso después de la infección por el SARS-CoV-2 Resultados: El Dr. Machado y sus coautores realizaron una extensa revisión bibliográfica, con la redacción de varios artículos científicos publicados en revistas de impacto. Se presentan un compendio de publicaciones, en las que se estudias las rutas utilizadas por el virus para atacar al sistema nervioso, tanto periférico (SNP), como central (SNC), el desarrollo del SDRA, como causa fundamental del fallecimiento de los pacientes, la llamada “hipoxia silente o feliz”, que confunde al médico que atiende a un paciente sin disnea, pero que quema etapas hacia el SDRA, con el consiguiente fallecimiento, la necesidad de usar el tempranamente método de ventilación a presión positiva (CPAP para evitar la hipoxemia que dispara la tormenta de citoquinas, y otros aspectos vinculados con la pato-fisiología provocada en el sistema nervioso (SN) durante esta enfermedad. Es importante señalar que como el Dr. Machado es Miembro Correspondiente de la Academia Americana de Neurología (AAN), el Presidente de dicha Academia le solicitó que evaluara y brindara su opinión de experto sobre artículos publicados en la revista “Neurology”, publicación oficial de la AAN. Conclusiones: Las diversas complicaciones provocadas en el SN por la infección del SARS-CoV-2 merecen una atención especial, y se pueden aplicar medidas tempranas para evitar la hipoxemia que dispara la tormenta de citoquinas, el síndrome de distrés respiratorio agudo, que pueden llevar a la muerte.
... However, a decline in SjvO 2 is observed in cases where the extent of ischemic injury is considerably large, thereby impeding early intervention aimed at mitigating the risk of cerebral damage [40]. Also, although early low flow velocities correlated with cerebral hypoxia [41], TCD cannot replace direct measurement of brain oxygenation to optimize brain hemodynamics in such patients. ...
Article
Full-text available
Purpose of Review Acute brain injury, whether resulting from trauma, ischemia, or other causes, presents a significant challenge in critical care medicine. The brain’s vulnerability necessitates a proactive approach to minimize secondary brain injuries that can have profound consequences. Multimodal monitoring of systemic and cerebral variables complements these efforts by providing continuous, objective data on brain physiology and pathophysiology, enabling timely interventions. Recent Findings Recent advancements have shown that integrating neuromonitoring with systemic variables allows for individualized care, minimizing secondary insults and promoting neuroprotection. This approach helps in minimizing secondary insults to the brain and promotes neuroprotection. However, challenges include the lack of standardized protocols for interpreting neuromonitoring data, potential variability in clinical decision-making, and the need for specialized expertise. Despite these advancements, there is limited data on protocolized care based on neuromonitoring values. Summary This review aims to summarize existing evidence on the role of goal-directed therapy in managing brain-injured patients. It has been highlighted the importance of multimodal neuromonitoring in enhancing patient outcomes and the need for further research and standardization in this area to improve the care of patients with acute brain injuries.
... TCD derived CBFV measurements also provide useful information regarding the competency of cerebral perfusion, with low values suggestive of oligemia, and have been linearly correlated with CBF using computed tomography perfusion (CTP) in patients with diffuse traumatic injury patterns (154). A low-flow state defined as MCA MFV below 40 cm/s, occurs in over half of TBI patients during the first 24 h after injury, most often ipsilateral to focal pathology and correlates with the burden of cerebral hypoxia (PbtO 2 <20 mmHg) (155,156). The combination of elevated PI (suggesting increased resistance) with MFV 35-40 cm/s or EDV <20-25 cm/s (signifying impaired CBF) identifies TBI patients with particularly high risk of poor outcome and has even been validated in a mixed ICU population of patients with coma for mortality (152,153,157,158). ...
Article
Full-text available
Given the complexity of cerebral pathology in patients with acute brain injury, various neuromonitoring strategies have been developed to better appreciate physiologic relationships and potentially harmful derangements. There is ample evidence that bundling several neuromonitoring devices, termed “multimodal monitoring,” is more beneficial compared to monitoring individual parameters as each may capture different and complementary aspects of cerebral physiology to provide a comprehensive picture that can help guide management. Furthermore, each modality has specific strengths and limitations that depend largely on spatiotemporal characteristics and complexity of the signal acquired. In this review we focus on the common clinical neuromonitoring techniques including intracranial pressure, brain tissue oxygenation, transcranial doppler and near-infrared spectroscopy with a focus on how each modality can also provide useful information about cerebral autoregulation capacity. Finally, we discuss the current evidence in using these modalities to support clinical decision making as well as potential insights into the future of advanced cerebral homeostatic assessments including neurovascular coupling.
... After TBI, patients may develop cerebral edema and undergo a phase of cerebral hypoperfusion (reduced CBF and elevated OEF) in the first 24 hours post-injury, followed by a hyperemia phase at 1-3 days after the injury [51]. Here, we observed an increase in ipsilateral and contralateral f H 2 O from 30 minutes to 24 hours post-injury, which may suggest brain swelling. ...
Article
Full-text available
In this study, we used diffuse optics to address the need for non-invasive, continuous monitoring of cerebral physiology following traumatic brain injury (TBI). We combined frequency-domain and broadband diffuse optical spectroscopy with diffuse correlation spectroscopy to monitor cerebral oxygen metabolism, cerebral blood volume, and cerebral water content in an established adult swine-model of impact TBI. Cerebral physiology was monitored before and after TBI (up to 14 days post injury). Overall, our results suggest that non-invasive optical monitoring can assess cerebral physiologic impairments post-TBI, including an initial reduction in oxygen metabolism, development of cerebral hemorrhage/hematoma, and brain swelling.
... Understanding the changes in CBF is helpful to detect new vascular injury during ECMO support and to optimize cerebral perfusion. TCD and TCCD have been applied to stroke, TBI, hypoxic-ischemic encephalopathy, and neurological monitoring during ECMO support (36)(37)(38)(39). Point-of-care ultrasound (PoCUS) visualization management of ECMO patients has played an important role in identifying indications, catheterization, flow adjustment, volume management, cardiac function evaluation, etc. ...
Article
Full-text available
Background The main objective of this study was to investigate the role of a multimodal neurological monitoring (MNM)-guided protocol in the precision identification of neural impairment and long-term neurological outcomes in venoarterial extracorporeal membrane oxygenation (VA-ECMO) supported patients. Methods We performed a cohort study that examined adult patients who underwent VA-ECMO support in our center between February 2010 and April 2021. These patients were retrospectively assigned to the “with MNM group” and the “without MNM group” based on the presence or absence of MNM-guided precision management. The differences in ECMO-related characteristics, evaluation indicators (precision, sensitivity, and specificity) of the MNM-guided protocol, and the long-term outcomes of the surviving patients were measured and compared between the two groups. Results A total of 63 patients with VA-ECMO support were retrospectively assigned to the without MNM group ( n = 35) and the with MNM group ( n = 28). The incidence of neural impairment in the without MNM group was significantly higher than that in the with MNM group (82.1 vs. 54.3%, P = 0.020). The MNM group exhibited older median ages [52.5 (39.5, 65.3) vs. 31 (26.5, 48.0), P = 0.008], a higher success rate of ECMO weaning (92.8 vs. 71.4%, P = 0.047), and a lower median duration of building ECMO [40.0 (35.0, 52.0) vs. 58.0 (48.0, 76.0), P = 0.025] and median ECMO duration days [5.0 (4.0, 6.2) vs. 7.0 (5.0, 10.5), P = 0.018] than the group without MNM. The MNM-guided protocol exhibited a higher precision rate (82.1 vs. 60.0%), sensitivity (95.7 vs. 78.9%), and specificity (83.3 vs. 37.5%) in identifying neural impairment in VA-ECMO support patients. There were significant differences in the long-term outcomes of survivors at 1, 3 and 6 months after discharge between the two groups ( P < 0.05). However, the results showed no significant differences in ICU length of stay (LOS), hospital LOS, survival to discharge, or 28-day mortality between the two groups ( P > 0.05). Conclusion The MNM-guided protocol is conducive to guiding intensivists in the improvement of cerebral protection therapy for ECMO-supported patients to detect and treat potential neurologic impairment promptly, and then improving long-term neurological outcomes after discharge.
Article
Moderate traumatic brain injury (TBI) is a diagnosis that describes diverse patients with heterogeneity of primary injuries. Defined by a Glasgow Coma Scale between 9 and 12, this category includes patients who may neurologically worsen and require increasing intensive care resources and/or emergency neurosurgery. Despite the unique characteristics of these patients, there have not been specific guidelines published before this effort to support decision-making in these patients. A Delphi consensus group from the Latin American Brain Injury Consortium was established to generate recommendations related to the definition and categorization of moderate TBI. Before an in-person meeting, a systematic review of the literature was performed identifying evidence relevant to planned topics. Blinded voting assessed support for each recommendation. A priori the threshold for consensus was set at 80% agreement. Nine PICOT questions were generated by the panel, including definition, categorization, grouping, and diagnosis of moderate TBI. Here, we report the results of our work including relevant consensus statements and discussion for each question. Moderate TBI is an entity for which there is little published evidence available supporting definition, diagnosis, and management. Recommendations based on experts' opinion were informed by available evidence and aim to refine the definition and categorization of moderate TBI. Further studies evaluating the impact of these recommendations will be required.
Article
Cerebral oxygenation represents the balance between oxygen delivery, consumption and utilization by the brain, and therefore reflects the adequacy of cerebral perfusion. Different factors can influence the amount of oxygen to the brain including arterial blood pressure, hemoglobin levels, systemic oxygenation, and transfer of oxygen from blood to the cerebral microcirculation. A mismatch between cerebral oxygen supply and demand results in cerebral hypoxia/ischemia, and is associated with secondary brain damage and worsened outcome after acute brain injury. Therefore, monitoring and prompt treatment of cerebral oxygenation compromise is warranted in both neuro and general intensive care unit populations. Several tools have been proposed for the assessment of cerebral oxygenation, including non-invasive/invasive or indirect/direct methods, including Jugular Venous Oxygen Saturation (SjO2), Partial Brain Tissue Oxygen Tension (PtiO2), Near infrared spectroscopy (NIRS), Transcranial Doppler, electroencephalography and Computed Tomography. In this manuscript, we aim to review the pathophysiology of cerebral oxygenation, describe monitoring technics, and generate recommendations for avoiding brain hypoxia in settings with low availability of resources for direct brain oxygen monitoring.
Conference Paper
The interest in optical healthcare technologies has increased significantly over the recent years. The innovation of new optical technologies such as Near Infrared Spectroscopy (NIRS), used for the monitoring of brain perfusion, demands a comprehensive understanding and knowledge of the light tissue interaction. Phantoms can provide a rigorous, reproducible and convenient approach for evaluating an optical sensor's performance. However, up to date literature does not provide a detailed description of a complete head model that involves the human anatomy, physiological changes, and the tissue optical properties. The latter is key for the design, development and testing of optical sensors, such as NIRS technologies. This paper compared the optical properties of the materials chosen to build a head phantom, against the optical properties of real brain and skull tissues extracted from animal models. The spectra of a silicone brain and resin skull samples were compared with the spectra of the respective tissues extracted from pigs and mice. The results of this study demonstrated that both phantom materials have similar optical properties to mice and pigs' tissues. The morphology of the phantom's spectra were very similar to the respective animal tissue comparator.
Chapter
Traumatic Brain Injury (TBI) is a major cause of death and disability in the USA, with lasting effects that impact the patient and their family. TBI pathophysiology is split into primary brain injury, and secondary brain injury like subarachnoid hemorrhage, increased intracranial pressure (ICP), and ischemia, all of which are predictors of poor TBI outcomes. Transcranial Doppler (TCD) is a noninvasive way to measure ICP, cerebral perfusion pressure, middle cerebral artery mean flow velocity (MFV), pulsatility index and other intracranial parameters in-vivo, allowing it to screen for the aforementioned secondary brain injuries. TCD is a good screening tool, in conjunction with head CT, for secondary neurologic deterioration in mild-moderate TBI. It has been shown to be effective in managing severe TBI by screening for low perfusion pressures. Normal TCD values vary by age, but early monitoring of and treatment of TCD parameters may improve TBI outcomes.KeywordsTrauma Brain injury Ultrasound Pulsatility index Transcranial Doppler
Article
Full-text available
OBJECTIVE Avoiding decreases in brain tissue oxygenation (PbtO 2 ) after traumatic brain injury (TBI) is important. How best to adjust PbtO 2 remains unclear. The authors investigated the association between partial pressure of oxygen (PaO 2 ) and PbtO 2 to determine the minimal PaO 2 required to maintain PbtO 2 above the hypoxic threshold (> 20 mm Hg), accounting for other determinants of PbtO 2 and repeated measurements in the same patient. They also explored the clinical utility of a novel concept, the brain oxygenation ratio (BOx ratio = PbtO 2 /PaO 2 ) to detect overtreatment with the fraction of inspired oxygen (FiO 2 ). METHODS A retrospective cohort study at an academic level 1 trauma center included 38 TBI patients who required the insertion of a monitor to measure PbtO 2 . Various determinants of PbtO 2 were collected simultaneously whenever a routine arterial blood gas was drawn. A PbtO 2 /PaO 2 ratio was calculated for each blood gas and plotted over time for each patient. All patients were managed according to a standardized clinical protocol. A mixed effects model was used to account for repeated measurements in the same patient. RESULTS A total of 1006 data points were collected. The lowest mean PaO 2 observed to maintain PbtO 2 above the ischemic threshold was 94 mm Hg. Only PaO 2 and cerebral perfusion pressure were predictive of PbtO 2 in multivariate analysis. The PbtO 2 /PaO 2 ratio was below 0.15 in 41.7% of all measures and normal PbtO 2 values present despite an abnormal ratio in 27.1% of measurements. CONCLUSIONS The authors’ results suggest that the minimal PaO 2 target to ensure adequate cerebral oxygenation during the first few days after TBI should be higher than that suggested in the Brain Trauma Foundation guidelines. The use of a PbtO 2 /PaO 2 ratio (BOx ratio) may be clinically useful and identifies abnormal O 2 delivery mechanisms (cerebral blood flow, diffusion, and cerebral metabolic rate of oxygen) despite normal PbtO 2 .
Article
Full-text available
The extent and timing of posttraumatic cerebral hemodynamic disturbances have significant implications for the monitoring and treatment of patients with head injury. This prospective study of cerebral blood flow (CBF) (measured using ¹³³ Xe clearance) and transcranial Doppler (TCD) measurements in 125 patients with severe head trauma has defined three distinct hemodynamic phases during the first 2 weeks after injury. The phases are further characterized by measurements of cerebral arteriovenous oxygen difference (AVDO 2 ) and cerebral metabolic rate of oxygen (CMRO 2 ). Phase I (hypoperfusion phase) occurs on the day of injury (Day 0) and is defined by a low CBF 15 calculated from cerebral clearance curves integrated to 15 minutes (mean CBF 15 32.3 ± 2 ml/100 g/minute), normal middle cerebral artery (MCA) velocity (mean V MCA 56.7 ± 2.9 cm/second), normal hemispheric index (mean HI 1.67 ± 0.11), and normal AVDO 2 (mean AVDO 2 5.4 ± 0.5 vol%). The CMRO 2 is approximately 50% of normal (mean CMRO 2 1.77 ± 0.18 ml/100 g/minute) during this phase and remains depressed during the second and third phases. In Phase II (hyperemia phase, Days 1-3), CBF increases (46.8 ± 3 ml/100 g/minute), AVDO 2 falls (3.8 ± 0.1 vol%), V MCA velocity rises (86 ± 3.7 cm/second), and the HI remains less than 3 (2.41 ± 0.1). In Phase III (vasospasm phase, Days 4-15), there is a fall in CBF (35.7 ± 3.8 ml/100 g/minute), a further increase in V MCA (96.7 ± 6.3 cm/second), and a pronounced rise in the HI (2.87 ± 0.22). This is the first study in which CBF, metabolic, and TCD measurements are combined to define the characteristics and time courses of, and to suggest etiological factors for, the distinct cerebral hemodynamic phases that occur after severe craniocerebral trauma. This research is consistent with and builds on the findings of previous investigations and may provide a useful temporal framework for the organization of existing knowledge regarding posttraumatic cerebrovascular and metabolic pathophysiology.
Article
Full-text available
Background: To assess the performance of transcranial Doppler (TCD) in predicting neurologic worsening after mild to moderate traumatic brain injury. Methods: The authors conducted a prospective observational study across 17 sites. TCD was performed upon admission in 356 patients (Glasgow Coma Score [GCS], 9 to 15) with mild lesions on cerebral computed tomography scan. Normal TCD was defined as a pulsatility index of less than 1.25 and diastolic blood flow velocity higher than 25 cm/s in the two middle cerebral arteries. The primary endpoint was secondary neurologic deterioration on day 7. Results: Twenty patients (6%) developed secondary neurologic deterioration within the first posttraumatic week. TCD thresholds had 80% sensitivity (95% CI, 56 to 94%) and 79% specificity (95% CI, 74 to 83%) to predict neurologic worsening. The negative predictive values and positive predictive values of TCD were 98% (95% CI, 96 to 100%) and 18% (95% CI, 11to 28%), respectively. In patients with minor traumatic brain injury (GCS, 14 to 15), the sensitivity and specificity of TCD were 91% (95% CI, 59 to 100%) and 80% (95% CI, 75 to 85%), respectively. The area under the receiver operating characteristic curve of a multivariate predictive model including age and GCS was significantly improved with the adjunction of TCD. Patients with abnormal TCD on admission (n = 86 patients) showed a more altered score for the disability rating scale on day 28 compared to those with normal TCD (n = 257 patients). Conclusions: TCD measurements upon admission may provide additional information about neurologic outcome after mild to moderate traumatic brain injury. This technique could be useful for in-hospital triage in this context.
Article
Full-text available
Importance We have previously combined oxygen-15 positron emission tomography (15O PET) and brain tissue oximetry (BptO2) to demonstrate increased oxygen diffusion gradients in hypoxic regions following traumatic brain injury (TBI). These data are consistent with microvascular ischaemia and are supported by pathological studies showing widespread microvascular collapse, perivascular oedema and microthrombosis associated with selective neuronal loss. 18F-fluoromisonidazole ([18F]FMISO), a PET tracer that undergoes irreversible selective bioreduction within hypoxic cells, could confirm these findings. Objective Combine ([18F]FMISO) and 15O PET to demonstrate the relative burden, distribution and physiological signatures of conventional macrovascular and microvascular ischaemia in early TBI. Design Observational. Setting Neurosciences Critical Care Unit. Participants Ten patients of median age 59 years (range 30–68) within 1-8 days of severe/moderate TBI, and two cohorts of 10 healthy volunteers aged 53 (41–76) and 45 (29–59) years. Exposures Cerebral blood flow (CBF), blood volume (CBV), oxygen metabolism (CMRO2), oxygen extraction fraction (OEF), and brain tissue hypoxia were measured in patients during combined 15O and [18F]FMISO PET imaging. Similar data were obtained from two cohorts of healthy volunteers who underwent either 15O or [18F]FMISO PET. Main Outcome Measures We estimated ischaemic brain volume (IBV) and hypoxic brain volume (HBV), and compared their spatial distribution and physiological signatures. Results Compared to controls, patients showed higher IBV (56(9 – 281) ml vs. 1(0 – 11) ml; p
Article
Full-text available
ObjectiveTo assess the use of hyperventilation and the adherence to Brain Trauma Foundation-Guidelines (BTF-G) after traumatic brain injury (TBI). SettingTwenty-two European centers are participating in the BrainIT initiative. DesignRetrospective analysis of monitoring data. Patients and participantsOne hundred and fifty-one patients with a known time of trauma and at least one recorded arterial blood–gas (ABG) analysis. Measurements and resultsA total number of 7,703 ABGs, representing 2,269 ventilation episodes (VE) were included in the analysis. Related minute-by-minute ICP data were taken from a 30min time window around each ABG collection. Data are given as mean with standard deviation. (1) Patients without elevated intracranial pressure (ICP) (<20mmHg) manifested a statistically significant higher PaCO2 (36±5.7mmHg) in comparison to patients with elevated ICP (≥20mmHg; PaCO2: 34±5.4mmHg, P<0.001). (2) Intensified forced hyperventilation (PaCO2≤25mmHg) in the absence of elevated ICP was found in only 49 VE (2%). (3) Early prophylactic hyperventilation (<24h after TBI; PaCO2≤35mmHg, ICP<20mmHg) was used in 1,224 VE (54%). (4) During forced hyperventilation (PaCO2≤30mmHg), simultaneous monitoring of brain tissue pO2 or SjvO2 was used in only 204 VE (9%). ConclusionWhile overall adherence to current BTF-G seems to be the rule, its recommendations on early prophylactic hyperventilation as well as the use of additional cerebral oxygenation monitoring during forced hyperventilation are not followed in this sample of European TBI centers. DescriptorNeurotrauma
Article
Objective: To examine the accuracy of brain multimodal monitoring-consisting of intracranial pressure, brain tissue PO2, and cerebral microdialysis--in detecting cerebral hypoperfusion in patients with severe traumatic brain injury. Design: Prospective single-center study. Patients: Patients with severe traumatic brain injury. Setting: Medico-surgical ICU, university hospital. Intervention: Intracranial pressure, brain tissue PO2, and cerebral microdialysis monitoring (right frontal lobe, apparently normal tissue) combined with cerebral blood flow measurements using perfusion CT. Measurements and main results: Cerebral blood flow was measured using perfusion CT in tissue area around intracranial monitoring (regional cerebral blood flow) and in bilateral supra-ventricular brain areas (global cerebral blood flow) and was matched to cerebral physiologic variables. The accuracy of intracranial monitoring to predict cerebral hypoperfusion (defined as an oligemic regional cerebral blood flow < 35 mL/100 g/min) was examined using area under the receiver-operating characteristic curves. Thirty perfusion CT scans (median, 27 hr [interquartile range, 20-45] after traumatic brain injury) were performed on 27 patients (age, 39 yr [24-54 yr]; Glasgow Coma Scale, 7 [6-8]; 24/27 [89%] with diffuse injury). Regional cerebral blood flow correlated significantly with global cerebral blood flow (Pearson r = 0.70, p < 0.01). Compared with normal regional cerebral blood flow (n = 16), low regional cerebral blood flow (n = 14) measurements had a higher proportion of samples with intracranial pressure more than 20 mm Hg (13% vs 30%), brain tissue PO2 less than 20 mm Hg (9% vs 20%), cerebral microdialysis glucose less than 1 mmol/L (22% vs 57%), and lactate/pyruvate ratio more than 40 (4% vs 14%; all p < 0.05). Compared with intracranial pressure monitoring alone (area under the receiver-operating characteristic curve, 0.74 [95% CI, 0.61-0.87]), monitoring intracranial pressure + brain tissue PO2 (area under the receiver-operating characteristic curve, 0.84 [0.74-0.93]) or intracranial pressure + brain tissue PO2+ cerebral microdialysis (area under the receiver-operating characteristic curve, 0.88 [0.79-0.96]) was significantly more accurate in predicting low regional cerebral blood flow (both p < 0.05). Conclusion: Brain multimodal monitoring-including intracranial pressure, brain tissue PO2, and cerebral microdialysis--is more accurate than intracranial pressure monitoring alone in detecting cerebral hypoperfusion at the bedside in patients with severe traumatic brain injury and predominantly diffuse injury.
Article
G*Power (Erdfelder, Faul, & Buchner, 1996) was designed as a general stand-alone power analysis program for statistical tests commonly used in social and behavioral research. G*Power 3 is a major extension of, and improvement over, the previous versions. It runs on widely used computer platforms (i.e., Windows XP, Windows Vista, and Mac OS X 10.4) and covers many different statistical tests of the t, F, and chi2 test families. In addition, it includes power analyses for z tests and some exact tests. G*Power 3 provides improved effect size calculators and graphic options, supports both distribution-based and design-based input modes, and offers all types of power analyses in which users might be interested. Like its predecessors, G*Power 3 is free.
Article
Object: In spite of evidence that use of the Brain Trauma Foundation Guidelines for the Management of Severe Traumatic Brain Injury (Guidelines) would dramatically reduce morbidity and mortality, adherence to these Guidelines remains variable across trauma centers. The authors analyzed 2-week mortality due to severe traumatic brain injury (TBI) from 2001 through 2009 in New York State and examined the trends in adherence to the Guidelines. Methods: The authors calculated trends in adherence to the Guidelines and age-adjusted 2-week mortality rates between January 1, 2001, and December 31, 2009. Univariate and multivariate logistic regression analyses were performed to evaluate the effect of time period on case-fatality. Intracranial pressure (ICP) monitor insertion was modeled in a 2-level hierarchical model using generalized linear mixed effects to allow for clustering by different centers. Results: From 2001 to 2009, the case-fatality rate decreased from 22% to 13% (p < 0.0001), a change that remained significant after adjusting for factors that independently predict mortality (adjusted OR 0.52, 95% CI 0.39-0.70; p < 0.0001). Guidelines adherence increased, with the percentage of patients with ICP monitoring increasing from 56% to 75% (p < 0.0001). Adherence to cerebral perfusion pressure treatment thresholds increased from 15% to 48% (p < 0.0001). The proportion of patients having an ICP elevation greater than 25 mm Hg dropped from 42% to 29% (p = 0.0001). Conclusions: There was a significant reduction in TBI mortality between 2001 and 2009 in New York State. Increase in Guidelines adherence occurred at the same time as the pronounced decrease in 2-week mortality and decreased rate of intracranial hypertension, suggesting a causal relationship between Guidelines adherence and improved outcomes. Our findings warrant future investigation to identify methods for increasing and sustaining adherence to evidence-based Guidelines recommendations.
Chapter
It is the general sense that mortality has been decreasing in recent years compared to earlier studies described by the NIH traumatic coma data bank. We studied mortality during the period of 1984 to 1996 to determine if indeed mortality from severe traumatic brain injury was decreasing and to identify factors which might account for the reduction. The study population (N = 1839) consisted of severely head injured patients extracted retrospectively from the TCDB (635), MCV (382), and 822 patients from clinical trial databases conducted in the United States. Mortality was obtained from each of the databases for the age range form 16 to 65. Penetrating injury and treatment groups in the clinical trial databases were excluded. Mortality in the year 1984 equaled 39% and gradually decreased to a level of 27% in 1996. When adjusting for age, motor score and pupil reaction, the mortality of the period from 1984 to 1987 was significantly higher (p < 0:05) than that of the period 1988 to 1996. During the period 1984 through 1996, mortality from severe brain injury steadily declined. Factors other than age, motor score and pupil reactivity over time are responsible for this reduction. This reduction over time is an important factor for prognostic modeling of TBI.